SITES (ANATOMICAL LOCATIONS) OF ENDOMETRIOSIS
PREDISPOSING (RISK) FACTORS FOR ENDOMETRIOSIS
Endometriosis and Adenomyosis
Endometriosis and Adenomyosis
HISTOLOGICAL (MICROSCOPIC) APPEARANCE OF ENDOMETRIOSIS
MALIGNANT CHANGE IN ENDOMETRIOSIS
Section six: Benign and Promalignant Lesions in Gynecology
CLINICAL FEATURES OF ENDOMETRIOSIS
CAUSES OF PAIN IN ENDOMETRIOSIS
Endometriosis and Adenomyosis
Section number Bpnigh and Premalignant Lesions in Gynecology
Nine Gastrointestinal conditions
Table twenty-five point two: Various investigations for diagnosis of endometriosis
Endometriosis and Adenomyosis
CLASSIFICATION AND STAGING OF ENDOMETRIOSIS
One. rASRM Classification nineteen ninety-seven (Revised American Society for Reproductive Medicine Classification)
Endometriosis and Adenoryenis-
AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE REVISED CLASSIFICATION OF ENDOMETRIOSIS (nineteen ninety-seven)
Section six: Benign and Premalignant Lesions in Gynecology
Three. The Endometriosis Fertility Index
Endometriosis and Adenomyosis
(i) Nonsteroidal anti-inflammatory drugs
GnRH agonists: Their use causes pituitary desensitization and inhibition of ovarian steroidogenesis.
(a) Goserelin three point six milligrams subcutaneously monthly (or ten point eight milligrams three monthly)
Dose: Elagolix - Low dose (one hundred fifty milligrams per day) and high dose (two hundred milligrams per day)
(vii) Selective progesterone receptor modulators (SPRMs): These drugs bind to progesterone
Superficial Endometriosis
Surgery for Ovarian Endometrioma
SURGICAL TREATMENT OF DEEP INTRATING ENDOMETRIOSIS AND ADVANCED DISEASE
RECURRENCE OF ENDOMETRIOSIS
PRE AND POSTOPERATIVE HORMONE REPLACEMENT
TREATMENT OF INFERTILITY IN ENDOMETRIOSIS
Endometriosis and Adenomyosis
ENDOMETRIOSIS IN ADOLESCENCE (ESHRE twenty twenty-two)
Section six: Benign and Premalignant Lesions in Gynecology
SCAR ENDOMETRIOSIS (Figure twenty-five point eight)
Endometriosis and Adenomyosis
Section six: Benign and Premalignant Lesions in Gynecology
INTERVENTIONAL TECHNIQUES